133 results on '"Calvo Alen, Jaime"'
Search Results
2. Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel
3. Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study
4. Impact of rheumatoid arthritis on sexuality: adaptation and validation of the Qualisex questionnaire for use in Spain
5. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis
6. Influence of prognosis factors on the prescription of targeted treatments in rheumatoid arthritis: A Delphi survey
7. HLA association with the susceptibility to anti-synthetase syndrome
8. Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology
9. Practical aspects of biological throught levels and antidrug antibodies in rheumatoid arthritis and spondyloarthritis
10. Efficacy and safety of combined therapy with synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: Systematic literature review
11. Desarrollo de una aplicación para teléfonos móviles (app) basada en la colaboración Sociedad Española de Reumatología/Sociedad Española de Medicina de Familia y Comunitaria para derivación de enfermedades autoinmunes sistémicas
12. Aspectos prácticos de la medición de los niveles de fármacos biológicos y de anticuerpos antifármaco en artritis reumatoide y espondiloartritis
13. Eficacia y seguridad de la terapia combinada con fármacos modificadores de la enfermedad sintéticos en la artritis reumatoide: revisión sistemática de la literatura
14. Expert recommendations on the interleukin 6 blockade in patients with rheumatoid arthritis
15. Recomendaciones de experto sobre el bloqueo de la interleucina 6 en pacientes con artritis reumatoide
16. Efficacy and safety of glucocorticoids in rheumatoid arthritis: Systematic literature review
17. Eficacia y seguridad de los glucocorticoides en la artritis reumatoide: revisión sistemática de la literatura
18. Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature
19. Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study.
20. Recommendations for the Use of Parenteral Methotrexate in Rheumatic Diseases
21. Recomendaciones sobre el uso de metrotexato parenteral en enfermedades reumáticas
22. Biologic Disease-modifying Antirheumatic Drug Attributes in the First Lines of Treatment of Rheumatoid Arthritis. 2015 ACORDAR Project
23. Atributos del fármaco antirreumático modificador de la enfermedad biológico en las primeras líneas de tratamiento de la artritis reumatoide. Proyecto ACORDAR 2015
24. LSO-089 Effectiveness of belimumab in systemic lupus erythematosus patients of a multicenter Spanish cohort
25. LP-191 Baseline profile of systemic lupus erythematosus patients on treatment with belimumab of a Spanish multicenter cohort
26. Corrigendum to “Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel” [Autoimmunity Reviews, Volume 22, Issue 12, December 2023, 103479]
27. Recommendations for the Use of Methotrexate in Rheumatoid Arthritis: Up and Down Scaling of the Dose and Administration Routes
28. Recomendaciones para el uso del metotrexato en artritis reumatoide: incremento y reducción de dosis y vías de administración
29. National Registry of Patients With Systemic Lupus Erythematosus of the Spanish Society of Rheumatology: Objectives and Methodology
30. Registro nacional de pacientes con lupus eritematoso sistémico de la Sociedad Española de Reumatología: objetivos y metodología
31. SER Consensus Statement on the Use of Biologic Therapy for Systemic Lupus Erythematosus
32. Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en el lupus eritematoso sistémico
33. Analysis of the rs20541 (R130Q) Polymorphism in the IL-13 Gene in Patients With Elderly-associated Chronic Inflammatory Diseases
34. Análisis del polimorfismo rs20541 (R130Q) del gen de la IL-13 en pacientes con enfermedades inflamatorias crónicas asociadas al envejecimiento
35. Ear, Nose and Throat Manifestations of Wegener's Granulomatosis (Granulomatosis With Polyangiitis)
36. Manifestaciones otorrinolaringológicas en pacientes con granulomatosis de Wegener (granulomatosis con poliangeitis)
37. Cytokine Gene Considerations in Giant Cell Arteritis: IL10 Promoter Polymorphisms and a Review of the Literature
38. Utilization of hyperestrogenic therapies in systemic lupus erythematosus
39. Utilización de terapias hiperestrogénicas en el lupus eritematoso sistémico
40. Tratamiento de situaciones clínicas difíciles en pacientes con artritis reumatoide: Embarazo
41. Infecciones graves en pacientes con terapia biológica
42. Nuevas dianas terapéuticas
43. Clinical Characteristics and Prognostic Factors in Patients with Hemophagocytic Syndrome
44. Current laboratory and clinical practices in reporting and interpreting anti-nuclear antibody indirect immunofluorescence (ANA IIF) patterns : results of an international survey
45. Beneficial Effect of Anti-TNF Therapy in the Lipoprotein Atherogenic Risk Profile in Comparison with DMARD Standard Therapy in RA Patients.: 1341
46. Lack of association between Toll-like receptor 4 gene polymorphisms and giant cell arteritis
47. Expression and function of toll-like receptors in peripheral blood mononuclear cells of patients with polymyalgia rheumatica and giant cell arteritis
48. Secondary Hemophagocytic Syndrome: Differences between the etiologies autoimmunes and hematological malignancies subgroup
49. Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. National multicenter study of 51 cases in clinical practice.
50. Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA Project
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.